Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 810

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 810
---
 development activities with respect to Licensed ADCs and/or Licensed Products, including nonclinical development, toxicology, pharmacology, statistical
analysis, Clinical Trials (including pre- and post-approval studies), regulatory affairs, and regulatory activities pertaining to designing and carrying out Clinical Trials and obtaining Regulatory Approvals
(excluding regulatory activities directed to obtaining pricing and reimbursement approvals) and (b) manufacturing process development and generation of chemistry, manufacturing and controls Data for Licensed ADCs and/or Licensed Products.

1.20 “DirectedTo” means, when used to describe the relationship between an ADC and a Licensed Target,
that the ADC (i) [***] the Licensed Target (or a portion thereof) and (ii) [***] to such Licensed Target (or such portion thereof).

1.21 “Divestiture” means, a Competing Product: (a) the divestiture of such Competing Product through
(i) an outright sale or assignment of all material rights in such Competing Product to a Third Party, (ii) an exclusive out-license to a Third Party of all Development and Commercialization rights
with respect to such Competing Product, with no further material role, influence or authority of the applicable Party, directly or indirectly, with respect to such Competing Product or (iii) a combination of the transactions contemplated by the
foregoing clauses (i) and (ii); or (b) the complete cessation of all Development and Commercialization activities with respect to such Competing Product. When used as a verb, “Divest” and “Divested” means
to cause or have caused a Divestiture.

1.22 “EMA” means the European Medicines Agency.

1.23 “Enforcement Action” means either an ADC Specific Enforcement Action or [***].

1.24 “Exploit” or “Exploitation” means, to make, have made, use, sell, offer for sale, import,
export, and otherwise exploit and have exploited, including Develop, Manufacture and Commercialize.

1.25 “EU”means the European Union, as its membership may be constituted from time to time, and any successor thereto.

1.26 “FDA” means the U.S. Food and Drug Administration, or any successor entity thereto performing similar
functions.

1.27 “Field” means any and all indications and uses.

1.28 “First Commercial Sale” means, on a Region-by-Region basis, the first commercial transfer or disposition
for monetary value of a Licensed Product in